Institution
Rio de Janeiro State University
Education•Rio de Janeiro, Brazil•
About: Rio de Janeiro State University is a education organization based out in Rio de Janeiro, Brazil. It is known for research contribution in the topics: Population & Large Hadron Collider. The organization has 16631 authors who have published 30919 publications receiving 465753 citations. The organization is also known as: UERJ & Rio de Janeiro State University.
Papers published on a yearly basis
Papers
More filters
••
Medical University of Graz1, University of London2, University of Genoa3, University of Leeds4, Mayo Clinic5, Charité6, Stony Brook University7, University of Barcelona8, Hospital of Southern Norway9, Harvard University10, Innsbruck Medical University11, University of Cambridge12, Rio de Janeiro State University13, University of KwaZulu-Natal14, Keele University15, University of Cantabria16, University of Kansas17, University of Gothenburg18, Hospital for Special Surgery19, Federal University of São Paulo20
TL;DR: In this article, the authors report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of polymyalgia rheumatica (PMR).
Abstract: Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the recommendations are based on the quality of evidence, the balance between desirable and undesirable effects, patients' and clinicians' values and preferences, and resource use. Eight overarching principles and nine specific recommendations were developed covering several aspects of PMR, including basic and follow-up investigations of patients under treatment, risk factor assessment, medical access for patients and specialist referral, treatment strategies such as initial glucocorticoid (GC) doses and subsequent tapering regimens, use of intramuscular GCs and disease modifying anti-rheumatic drugs (DMARDs), as well as the roles of non-steroidal anti-rheumatic drugs and non-pharmacological interventions. These recommendations will inform primary, secondary and tertiary care physicians about an international consensus on the management of PMR. These recommendations should serve to inform clinicians about best practices in the care of patients with PMR.
244 citations
••
VU University Medical Center1, University of Crete2, North Shore-LIJ Health System3, Dresden University of Technology4, Karolinska Institutet5, New York University6, University of São Paulo7, University of Groningen8, National and Kapodistrian University of Athens9, University of Manchester10, University of Calgary11, Lupus Foundation of America12, University of Paris13, Semmelweis University14, University of Pécs15, Utrecht University16, University of Padua17, Charité18, University of Düsseldorf19, University of Birmingham20, Medical University of Graz21, Université catholique de Louvain22, University College London23, University of Cambridge24, University of Mainz25, Paris Descartes University26, Rio de Janeiro State University27, University of Paris-Sud28, Monash University29, University of Pisa30, Istanbul University31, University of Santo Tomas32, Johns Hopkins University33, Tel Aviv University34, Medical University of Vienna35, University of Brescia36, University of Toronto37, University of Porto38, University of Southern Denmark39, Veterans Health Administration40, Hairmyres Hospital41, National Institutes of Health42
TL;DR: An international task force of 60 specialists and patient representatives agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions, which provides a framework for testing different definitions of remission against long-term outcomes.
Abstract: Objectives Treat-to-target recommendations have identified ‘remission’ as a target in systemic lupus erythematosus (SLE), but recognise that there is no universally accepted definition for this. Therefore, we initiated a process to achieve consensus on potential definitions for remission in SLE. Methods An international task force of 60 specialists and patient representatives participated in preparatory exercises, a face-to-face meeting and follow-up electronic voting. The level for agreement was set at 90%. Results The task force agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions: 1. Definitions of remission will be worded as follows: remission in SLE is a durable state characterised by …………………. (reference to symptoms, signs, routine labs). 2. For defining remission, a validated index must be used, for example, clinical systemic lupus erythematosus disease activity index (SLEDAI)=0, British Isles lupus assessment group (BILAG) 2004 D/E only, clinical European consensus lupus outcome measure (ECLAM)=0; with routine laboratory assessments included, and supplemented with physician9s global assessment. 3. Distinction is made between remission off and on therapy: remission off therapy requires the patient to be on no other treatment for SLE than maintenance antimalarials; and remission on therapy allows patients to be on stable maintenance antimalarials, low-dose corticosteroids (prednisone ≤5 mg/day), maintenance immunosuppressives and/or maintenance biologics. The task force also agreed that the most appropriate outcomes (dependent variables) for testing the prognostic value (construct validity) of potential remission definitions are: death, damage, flares and measures of health-related quality of life. Conclusions The work of this international task force provides a framework for testing different definitions of remission against long-term outcomes.
243 citations
••
TL;DR: For instance, in a study conducted by the Inquerito nacional de alimentacao (INQA) as mentioned in this paper, 34.003 individuos with dez anos ou mais de idade responded to a questionnaire about their consumption of alimentos.
Abstract: OBJETIVO: Caracterizar o consumo alimentar mais frequente da populacao brasileira. METODOS: Foram analisados dados referentes ao primeiro dia de registro alimentar de 34.003 individuos com dez anos ou mais de idade que responderam ao Inquerito Nacional de Alimentacao, composto por amostra probabilistica da Pesquisa de Orcamentos Familiares 2008-2009. O padrao de consumo foi analisado segundo sexo, grupo etario, regiao e faixa de renda familiar per capita. RESULTADOS: Os alimentos mais frequentemente referidos pela populacao brasileira foram arroz (84,0%), cafe (79,0%), feijao (72,8%), pao de sal (63,0%) e carne bovina (48,7%), destacando-se tambem o consumo de sucos e refrescos (39,8%), refrigerantes (23,0%) e menor presenca de frutas (16,0%) e hortalicas (16,0%). Essa configuracao apresenta pouca variacao quando se consideram os estratos de sexo e faixa etaria; contudo, observa-se que os adolescentes foram o unico grupo etario que deixou de citar qualquer hortalica e que incluiu doces, bebida lactea e biscoitos doces entre os itens mais consumidos. Alimentos marcadamente de consumo regional incluem a farinha de mandioca no Norte e Nordeste e o cha na regiao Sul. Houve discrepâncias no consumo alimentar entre os estratos de menor e maior renda: individuos no quarto de renda mais elevada referiram sanduiches, tomate e alface e aqueles no primeiro quarto de renda citaram os peixes e preparacoes a base de peixe e farinha de mandioca entre os alimentos mais referidos. CONCLUSOES: Existe um padrao basico do consumo alimentar no Brasil que inclui entre os alimentos mais consumidos arroz, cafe, feijao, pao de sal e carne bovina, associado ao consumo regional de alguns poucos itens. Particularmente entre os adolescentes, alimentos ricos em gordura e acucar sao tambem de consumo frequente.
243 citations
••
Vardan Khachatryan, Albert M. Sirunyan, Armen Tumasyan, Wolfgang Adam1 +2193 more•Institutions (152)
TL;DR: In this article, the authors measured the Upsilon production cross section in proton-proton collisions at 7 TeV using a data sample collected with the CMS detector at the LHC, corresponding to an integrated luminosity of 3.1 +/- 0.81 nb.
Abstract: The Upsilon production cross section in proton-proton collisions at sqrt(s) = 7 TeV is measured using a data sample collected with the CMS detector at the LHC, corresponding to an integrated luminosity of 3.1 +/- 0.3 inverse picobarns. Integrated over the rapidity range |y|<2, we find the product of the Upsilon(1S) production cross section and branching fraction to dimuons to be sigma(pp to Upsilon(1S) X) B(Upsilon(1S) to mu+ mu-) = 7.37 +/- 0.13^{+0.61}_{-0.42}\pm 0.81 nb, where the first uncertainty is statistical, the second is systematic, and the third is associated with the estimation of the integrated luminosity of the data sample. This cross section is obtained assuming unpolarized Upsilon(1S) production. If the Upsilon(1S) production polarization is fully transverse or fully longitudinal the cross section changes by about 20%. We also report the measurement of the Upsilon(1S), Upsilon(2S), and Upsilon(3S) differential cross sections as a function of transverse momentum and rapidity.
241 citations
••
Vardan Khachatryan, Albert M. Sirunyan, Armen Tumasyan, Wolfgang Adam1 +2137 more•Institutions (148)
TL;DR: The second-order azimuthal anisotropy Fourier Fourier harmonics, v2, obtained in p-Pb and PbPb collisions over a wide pseudorapidity range based on correlations among six or more charged particles support the interpretation of a collective origin for the previously observed long-range (large Δη) correlations in both systems.
Abstract: The second-order azimuthal anisotropy Fourier harmonics, v2, are obtained in pPb and PbPb collisions over a wide pseudorapidity (eta) range based on correlations among six or more charged particles. The pPb data, corresponding to an integrated luminosity of 35 inverse nanobarns, were collected during the 2013 LHC pPb run at a nucleon-nucleon center-of-mass energy of 5.02 TeV by the CMS experiment. A sample of semi-peripheral PbPb collision data at sqrt(s[NN])= 2.76 TeV, corresponding to an integrated luminosity of 2.5 inverse microbarns and covering a similar range of particle multiplicities as the pPb data, is also analyzed for comparison. The six- and eight-particle cumulant and the Lee-Yang zeros methods are used to extract the v2 coefficients, extending previous studies of two- and four-particle correlations. For both the pPb and PbPb systems, the v2 values obtained with correlations among more than four particles are consistent with previously published four-particle results. These data support the interpretation of a collective origin for the previously observed long-range (large Delta[eta]) correlations in both systems. The ratios of v2 values corresponding to correlations including different numbers of particles are compared to theoretical predictions that assume a hydrodynamic behavior of a pPb system dominated by fluctuations in the positions of participant nucleons. These results provide new insights into the multi-particle dynamics of collision systems with a very small overlapping region.
240 citations
Authors
Showing all 16818 results
Name | H-index | Papers | Citations |
---|---|---|---|
Hyun-Chul Kim | 176 | 4076 | 183227 |
Maria Elena Pol | 139 | 1414 | 99240 |
Wagner Carvalho | 135 | 1395 | 94184 |
Alberto Santoro | 135 | 1576 | 100629 |
Andre Sznajder | 134 | 1464 | 98242 |
Luiz Mundim | 133 | 1413 | 89792 |
Helio Nogima | 132 | 1274 | 84368 |
D. De Jesus Damiao | 128 | 1162 | 82707 |
Magdalena Malek | 128 | 598 | 67486 |
Sudha Ahuja | 127 | 1016 | 75739 |
Helena Malbouisson | 125 | 1151 | 82692 |
Jose Chinellato | 123 | 1116 | 64267 |
Flavia De Almeida Dias | 120 | 590 | 59083 |
Gilvan Alves | 119 | 829 | 69382 |
C. De Oliveira Martins | 119 | 880 | 66744 |